The initial autoantibody response against GAD has been shown to occur mostly against the M- and C-terminal epitopes among progressors to T1D whereas isolated responses toward the N-epitope do not increase the risk for T1D (3,4,26,27). The gene discussed is GAD1; the disease is type 1 diabetes mellitus.